 "Zydus acquires derma brand Melgain from Issar Pharma")
Stada Arzneimittel AG, the German manufacturer of generic and OTC (over-the-counter) drugs, has confirmed that it has received two legally non-binding expressions of interest regarding a bid for the acquisition of up to 100 percent of the shares in the company.
One of the proposal was submitted by private equity group Cinven Partners LLP at an indicative takeover price of Euro 56.00 per Stada share – the cumulative value of which amounts to € 3.5 billion. Stada received the second proposal from Advent International Corporation.
“Both legally non-binding expressions of interest from Cinven Partners LLP and from Advent International Corporation, which the
